1. Home
  2. SKYW vs SRRK Comparison

SKYW vs SRRK Comparison

Compare SKYW & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYW
  • SRRK
  • Stock Information
  • Founded
  • SKYW 1972
  • SRRK 2012
  • Country
  • SKYW United States
  • SRRK United States
  • Employees
  • SKYW N/A
  • SRRK N/A
  • Industry
  • SKYW Air Freight/Delivery Services
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SKYW Consumer Discretionary
  • SRRK Health Care
  • Exchange
  • SKYW Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • SKYW 4.2B
  • SRRK 4.2B
  • IPO Year
  • SKYW N/A
  • SRRK 2018
  • Fundamental
  • Price
  • SKYW $107.83
  • SRRK $43.21
  • Analyst Decision
  • SKYW Buy
  • SRRK Strong Buy
  • Analyst Count
  • SKYW 4
  • SRRK 7
  • Target Price
  • SKYW $107.25
  • SRRK $40.43
  • AVG Volume (30 Days)
  • SKYW 354.2K
  • SRRK 985.7K
  • Earning Date
  • SKYW 01-30-2025
  • SRRK 11-12-2024
  • Dividend Yield
  • SKYW N/A
  • SRRK N/A
  • EPS Growth
  • SKYW N/A
  • SRRK N/A
  • EPS
  • SKYW 5.85
  • SRRK N/A
  • Revenue
  • SKYW $3,335,305,000.00
  • SRRK N/A
  • Revenue This Year
  • SKYW $21.31
  • SRRK N/A
  • Revenue Next Year
  • SKYW $8.48
  • SRRK N/A
  • P/E Ratio
  • SKYW $18.98
  • SRRK N/A
  • Revenue Growth
  • SKYW 16.42
  • SRRK N/A
  • 52 Week Low
  • SKYW $48.28
  • SRRK $6.76
  • 52 Week High
  • SKYW $117.51
  • SRRK $46.19
  • Technical
  • Relative Strength Index (RSI)
  • SKYW 51.61
  • SRRK 54.30
  • Support Level
  • SKYW $104.06
  • SRRK $38.72
  • Resistance Level
  • SKYW $113.04
  • SRRK $46.13
  • Average True Range (ATR)
  • SKYW 3.25
  • SRRK 2.50
  • MACD
  • SKYW 0.82
  • SRRK -0.82
  • Stochastic Oscillator
  • SKYW 53.99
  • SRRK 52.08

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines and SkyWest Leasing.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Share on Social Networks: